Shanghai, China

Xinxing Tang


 

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Xinxing Tang

Introduction: Xinxing Tang is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of medicinal chemistry. With three patents to his name, he has focused his research on the development of intermediates for SGLT2 inhibitors, a class of drugs used in diabetes management. His innovative methods have paved the way for improved therapeutic options.

Latest Patents: Among Tang's notable patents is the preparation of hydroxy-benzylbenzene derivatives, which outlines methods for creating intermediates of SGLT2 inhibitors. This patent emphasizes the importance of crystalline forms and methods of crystallizing these intermediates, which are vital for enhancing the efficacy of pharmaceutical compounds.

Career Highlights: Throughout his career, Xinxing Tang has demonstrated exceptional expertise in the pharmaceutical industry. His work with Theracos Sub, LLC and Theracos, Inc. has showcased his ability to merge scientific knowledge with practical applications, driving advancements in drug development and formulation.

Collaborations: Tang has collaborated with esteemed professionals in his field, including Jacques Y Roberge and Ge Xu. These partnerships have been instrumental in fostering innovation and overcoming challenges in the complex landscape of drug discovery and chemical synthesis.

Conclusion: Xinxing Tang's contributions to the field of medicinal chemistry are commendable. His patents not only reflect his innovative spirit but also signify his commitment to improving healthcare through scientific advancement. As his career progresses, he will undoubtedly continue to make significant strides in the development of pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…